Procter & Gamble Co (NYSE: PG) shares suffered a steep stumble through the first four months of the year, but the second quarter saw some long-awaited relief. Unfortunately, the recovery isn’t expected to last much longer. Jefferies analyst Kevin Grundy downgraded Procter and Gamble to Hold and cut his price target from $83 to $79. SourceUpside seems to be over due to stochastics. The price will test the lower edge soon. $PG, Procter & Gamble Company (The) / D